Skip to main content
HR 3223 116th Congress House

Pharmacy Benefit Manager Accountability Study Act of 2019

Official title: To require the Comptroller General of the United States to study the role pharmacy benefit managers play in the pharmaceutical supply chain and to provide Cong… Show full official titleShow less

Official title: To require the Comptroller General of the United States to study the role pharmacy benefit managers play in the pharmaceutical supply chain and to provide Congress with appropriate policy recommendations, and for other purposes.

Introduced: June 12, 2019 Introduced by: Marshall, Roger Republican · Kansas See on congress.gov
Health Competition and antitrustCongressional oversightConsumer affairsDrug therapy
More subjectsShow fewer subjects
Government studies and investigationsHealth care costs and insuranceHealth care coverage and accessInflation and pricesPrescription drugsUser charges and fees
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 13, 2019
Referred to the Subcommittee on Health.
Jun 12, 2019
Referred to the House Committee on Energy and Commerce.
Jun 12, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 13, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Pharmacy Benefit Manager Accountability Study Act of 2019

This bill requires the Government Accountability Office to study the role of pharmacy benefit managers (PBMs) with respect to federally facilitated exchanges, including the role of PBMs in pharmaceutical supply chains, the competition among PBMs, and the use of rebates and fees by PBMs in such exchanges.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 3
All 3 Democratic 2 Republican 1
R
Carter, Earl L. "Buddy"
Georgia · Jun 12, 2019
 D
Gonzalez, Vicente
Texas · Jun 12, 2019
 D
Welch, Peter
Vermont · Jun 12, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3223: Pharmacy Benefit Manager Accountability Study Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-3223/
MLA
"H.R. 3223: Pharmacy Benefit Manager Accountability Study Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-3223/.
Bluebook (legal)
H.R. 3223, 116th Cong. (2026), https://openamerica.io/bill/116-HR-3223/.
Markdown link
[H.R. 3223: Pharmacy Benefit Manager Accountability Study Act of 2019](https://openamerica.io/bill/116-HR-3223/)
Report a problem